scholarly journals A Study of Rare Cases of Head and Neck Region in a Tertiary Care Centre in Last Three Years

2019 ◽  
Vol 7 (5) ◽  
Author(s):  
Dr Manisha Mahata ◽  
Keyword(s):  
Head And Neck ◽  
Tertiary Care ◽  
Neck Region ◽  
Care Centre ◽  
Tertiary Care Centre ◽  
Head And Neck Region

scholarly journals Extrapulmonary head and neck tuberculosis: 3 year experience at a tertiary care centre

2021 ◽  
Vol 7 (9) ◽  
pp. 1486
Author(s):  
Ashok Vivekanand ◽  
Prajwal S. Fernandes ◽  
Nair Tara
Keyword(s):  
Head And Neck ◽  
Tertiary Care ◽  
Neck Region ◽  
Tertiary Care Centre ◽  
Cervical Lymph Nodes ◽  
Head And Neck Region ◽  
Pulmonary Tb ◽  
Level Ii ◽  
Appropriate Treatment ◽  
Clinical Presentations

<p class="abstract"><strong>Background:</strong> Tuberculosis (TB) is a disease caused by Mycobacterium group of microbe. Most common manifestation of the disease is pulmonary TB. Involvement of other sites is termed as extrapulmonary TB (EPTB). These extrapulmonary sites are head and neck region, renal system, pleura, central nervous system and bones. This study was to find out the various head and neck manifestations of TB.</p><p class="abstract"><strong>Methods:</strong> All head and neck cases of TB diagnosed during the period 2017-2020 were included in the study. Recurrent cases of TB and those patients with primary pulmonary TB focus having head and neck manifestation were excluded from the study.</p><p class="abstract"><strong>Results: </strong>63 patients fulfilled the inclusion and exclusion criteria. The disease was found to be more in females (65.07%). The most common EPTB manifestation in head and neck region was the involvement of cervical lymph nodes followed by laryngeal TB. Level II was the most common involved lymph node group. We noted three cases of temporal bone TB and one case of nasal TB.</p><p class="abstract"><strong>Conclusions: </strong>In regions where the disease is endemic, there can be various atypical clinical presentations. Early diagnosis is of utmost importance in initiation of appropriate treatment.</p>

scholarly journals A study of FNAC of head and neck lesions at a tertiary care centre

2018 ◽  
Vol 4 (8) ◽  
pp. 592-596
Author(s):  
Dr. Bhumi Padia ◽  
◽  
Dr. Mukund Dhokiya ◽  
Keyword(s):  
Head And Neck ◽  
Tertiary Care ◽  
Care Centre ◽  
Tertiary Care Centre

Non-hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer center

2011 ◽  
Vol 27 (9) ◽  
pp. 919-923 ◽  
Author(s):  
Kunal Das ◽  
Sandeep Jain ◽  
Akanksha Chichra ◽  
Himesh Gupta ◽  
Gauri Kapoor
Keyword(s):  
Head And Neck ◽  
Tertiary Care ◽  
Neck Region ◽  
Cancer Center ◽  
Age Group ◽  
Pediatric Age ◽  
Head And Neck Region ◽  
Pediatric Age Group ◽  
Hematological Tumors

Critical review of the follow-up protocol for head and neck cancer patients

2019 ◽  
Vol 133 (05) ◽  
pp. 424-429 ◽  
Author(s):  
E Kytö ◽  
E Haapio ◽  
H Minn ◽  
H Irjala
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Recurrent Disease ◽  
Tertiary Care ◽  
Easy Access ◽  
Care Centre ◽  
Tertiary Care Centre

AbstractObjectiveHead and neck cancer follow-up length, interval and content are controversial. Therefore, this study aimed to evaluate the efficacy of the follow-up protocol after curative treatment in head and neck cancer patients.MethodClinical data of 456 patients with new malignancy of the head and neck from a tertiary care centre district from 1999 to 2008 were analysed. Time from treatment, symptoms and second-line treatment outcomes of patients with recurrent disease were evaluated.ResultsA total of 94 (22 per cent) patients relapsed during the 5-year follow-up period; 90 per cent of recurrences were found within 3 years. Fifty-six per cent of the patients had subjective symptoms indicating a recurrence of the tumour. All recurrent tumours found during routine follow-up visits without symptoms were found within 34 months after completion of treatment.ConclusionRoutine follow up after three years is questionable; recurrent disease beyond this point was detected in only 2 per cent of patients. In this study, all late tumour recurrences had symptoms of the disease. Easy access to extra follow-up visits when symptoms occur could cover the need for late follow up.

Sign in / Sign up

Export Citation Format

Share Document